GEHC GE HealthCare Technologies Inc. stock chart & analysis
Conviction 22HealthcareScan · Fri, Nov 6, 2026GE HealthCare Technologies Inc. (GEHC) closed at $82.38 (-1.64%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 72, RS Rating 84, -8.2% from its 52-week high, +0.4% year to date. Sector: Healthcare · X-Ray Apparatus & Tubes & Related Irradiation Apparatus.
Financials as of Wed, Sep 30, 2026 · quarterly.
GEHC technical analysis
Trend
GEHC's moving averages are mixed — no clean uptrend or downtrend. It closed 18.8% above the 50-day ($69.32) and 17.9% above the 200-day ($69.85). ADX(14) at 44 points to a strong, established trend. It meets 5 of 8 trend-template criteria.
Momentum
RSI(14) is 72, in overbought territory. The MACD histogram is positive. Its RS Rating of 84 puts its weighted 12-month performance ahead of about 84% of the US market.
Volume and volatility
Volume on the latest session ran 1.0× its 20-day average. It trades about $334.5M a day on average. ATR(14) is $2.61, 3.2% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.08) shows accumulation.
Key levels
The chart pattern's support is $63.23 and its resistance $79.44. The 52-week range is $58.75 to $89.77; price is 8.2% below the high and 40.2% above the low. The VWAP anchored at the 52-week high is $69.41, below price.
Performance
GEHC returned +7.6% (1 week), +28.3% (1 month), +12.9% (3 months), +29.8% (6 months), +8.9% (1 year), +0.4% (year to date).
About GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
X-Ray Apparatus & Tubes & Related Irradiation Apparatus · Listed 2022 · 54,000 employees
Congress activity
Disclosed STOCK Act trades in GEHC · 8 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
RK Rohit Khanna house · CA | Other | — | — | 2026-08-07 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 Warren Davidson house · OH · traded 2026-03-23 | Sell | $1K–$15K | 2026-03-23 | 2026-03-23 | |
RK Rohit Khanna house · CA | Other | — | — | 2026-03-09 | |
 Austin Scott house · R · GA · traded 2025-03-27 | Sell | $1K–$15K | 2025-03-27 | 2025-08-13 | |
 Rob Bresnahan house · PA · traded 2025-05-15 | Buy | $1K–$15K | 2025-05-15 | 2025-05-31 | |
Rob Bresnahan house · PA · traded 2025-04-08 | Sell | $1K–$15K | 2025-04-08 | 2025-04-28 | |
Rob Bresnahan house · PA · traded 2025-02-25 | Buy | $1K–$15K | 2025-02-25 | 2025-03-27 |
Insider activity
SEC Form 4 transactions in GEHC · open-market 3 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Holton Adam Y Chief People Officer · Common Stock, par value $0.01 per share · 2026-08-15 | Tax | 1.36K | $100K | 2026-08-15 | 2026-08-18 |
Lobo Kevin Director · Common Stock, par value $0.01 per share · 2026-05-22 | Buy | 10K | $642K | 2026-05-22 | 2026-05-26 |
Bankes Jeannette CEO, Patient Care Solutions · Common Stock, par value $0.01 per share · 2026-05-15 | Tax | 5.54K | $347K | 2026-05-15 | 2026-05-19 |
Rackliffe Philip CEO, AIS · Common Stock, par value $0.01 per share · 2026-05-15 | Grant | 16.46K | $0 | 2026-05-15 | 2026-05-19 |
Hochman Rodney F Director · Common Stock, par value $0.01 per share · 2026-05-12 | Buy | 1.62K | $100K | 2026-05-12 | 2026-05-13 |
Hochman Rodney F Director · Common Stock, par value $0.01 per share · 2026-05-12 | Other | — | — | 2026-05-12 | 2026-05-13 |
Yang Watkin Phoebe L. Director · Common Stock, par value $0.01 per share · 2026-05-08 | Buy | 1K | $63K | 2026-05-08 | 2026-05-11 |
CULP H LAWRENCE JR Director · Common Stock, par value $0.01 per share · 2026-05-07 | Other | — | — | 2026-05-07 | 2026-05-11 |
CULP H LAWRENCE JR Director · Common Stock, par value $0.01 per share · 2026-05-07 | Grant | 3.59K | $0 | 2026-05-07 | 2026-05-11 |
Lobo Kevin Director · Common Stock, par value $0.01 per share · 2026-05-07 | Grant | 3.59K | $0 | 2026-05-07 | 2026-05-11 |
SEC filings
EDGAR filings in GEHC · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.